RXRX Institutional Ownership & Shareholders
RECURSION PHARMACEUTICALS-A (RXRX) is currently held by 325 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.33B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of RXRX tracked by InsiderSet, reporting ownership valued at approximately $184.62M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $202.73M, representing an estimated gain of +9.81% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 69% of the total disclosed RXRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., ARK Invest, State Street Corp, and several other long-term asset managers with concentrated positions in RECURSION PHARMACEUTICALS-A (RXRX).
This page ranks the largest institutional RXRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
325
Total Reported Value
$1.33B
Largest Holder
Blackrock, Inc.
Largest Position
$184.62M
Insider Transactions (90d)
11
Latest Filing Quarter
Q2 2026
New Institutional Positions
43
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 50,304,691 | $184,618,217 | $202,727,905 | +$18,109,688 | +9.81% | |
| ARK Invest | Cathie Wood | 0.98% | 41,337,632 | $151,709,111 | $166,590,657 | +$14,881,546 | +9.81% |
| State Street Corp | 0.00% | 34,706,130 | $127,371,497 | $139,865,704 | +$12,494,207 | +9.81% | |
| Vanguard Portfolio Management Llc | 0.01% | 31,131,599 | $114,252,968 | $125,460,344 | +$11,207,376 | +9.81% | |
| Baillie Gifford & Co | 0.08% | 23,487,907 | $86,200,618 | $94,656,265 | +$8,455,647 | +9.81% | |
| Vanguard Capital Management Llc | 0.00% | 22,765,940 | $83,551,000 | $91,746,738 | +$8,195,738 | +9.81% | |
| Geode Capital Management, Llc | 0.00% | 13,819,135 | $50,724,628 | $55,691,114 | +$4,966,486 | +9.79% | |
| Softbank Group Corp. | 0.28% | 13,636,515 | $50,046,010 | $54,955,155 | +$4,909,145 | +9.81% | |
| Mic Capital Management Uk Llp | 8.98% | 9,644,033 | $35,393,601 | $38,865,453 | +$3,471,852 | +9.81% | |
| Ubs Group Ag | 0.01% | 8,947,102 | $32,835,865 | $36,056,821 | +$3,220,956 | +9.81% | |
| Norges Bank | 0.00% | 6,833,534 | $25,079,070 | $27,539,142 | +$2,460,072 | +9.81% | |
| Data Collective Iv Gp, Llc | 27.76% | 5,941,120 | $21,803,910 | $23,942,714 | +$2,138,804 | +9.81% | |
| Sumitomo Mitsui Trust Group, Inc. | 0.01% | 4,943,983 | $20,418,650 | $19,924,251 | -$494,399 | -2.42% | |
| Amova Asset Management Americas, Inc. | 0.26% | 5,511,687 | $20,227,891 | $22,212,099 | +$1,984,208 | +9.81% | |
| Northern Trust Corp | 0.00% | 4,758,236 | $17,462,727 | $19,175,691 | +$1,712,964 | +9.81% | |
| Marshall Wace, Llp | 0.01% | 4,714,577 | $17,302,499 | $18,999,745 | +$1,697,246 | +9.81% | |
| Charles Schwab Investment Management Inc | 0.00% | 4,138,286 | $15,187,510 | $16,677,293 | +$1,489,783 | +9.81% | |
| Dcvc Opportunity Fund Ii Gp, Llc | 84.30% | 3,951,141 | $14,500,687 | $15,923,098 | +$1,422,411 | +9.81% | |
| Goldman Sachs Group Inc | 0.00% | 3,917,858 | $14,378,538 | $15,788,968 | +$1,410,430 | +9.81% | |
| Vanguard Fiduciary Trust Co | 0.00% | 3,470,558 | $12,736,948 | $13,986,349 | +$1,249,401 | +9.81% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 4,023,398 | $12,351,832 | $16,214,294 | +$3,862,462 | +31.27% | |
| Two Sigma Investments, Lp | 0.01% | 3,353,658 | $12,307,925 | $13,515,242 | +$1,207,317 | +9.81% | |
| Susquehanna International Group, Llp | 0.01% | 3,292,128 | $12,082,110 | $13,267,276 | +$1,185,166 | +9.81% | |
| First Trust Advisors Lp | 0.01% | 3,041,829 | $11,163,512 | $12,258,571 | +$1,095,059 | +9.81% | |
| Morgan Stanley | 0.00% | 2,743,499 | $10,068,644 | $11,056,301 | +$987,657 | +9.81% | |
| Iq Eq Fund Management (Ireland) Ltd | 0.61% | 2,604,317 | $9,557,843 | $10,495,398 | +$937,555 | +9.81% | |
| Bank Of America Corp | 0.00% | 2,597,478 | $9,532,744 | $10,467,836 | +$935,092 | +9.81% | |
| Millennium Management Llc | 0.00% | 1,834,762 | $6,733,577 | $7,394,091 | +$660,514 | +9.81% | |
| Nuveen, Llc | 0.00% | 1,721,154 | $6,316,635 | $6,936,251 | +$619,616 | +9.81% | |
| Bank Of New York Mellon Corp | 0.00% | 1,639,167 | $6,015,742 | $6,605,843 | +$590,101 | +9.81% | |
| Jpmorgan Chase & Co | 0.00% | 1,146,516 | $4,316,647 | $4,620,459 | +$303,812 | +7.04% | |
| Jump Financial, Llc | 0.03% | 1,019,173 | $3,740,365 | $4,107,267 | +$366,902 | +9.81% | |
| Quadrature Capital Ltd | 0.03% | 987,798 | $3,625,219 | $3,980,826 | +$355,607 | +9.81% | |
| Swiss National Bank | 0.00% | 942,600 | $3,459,342 | $3,798,678 | +$339,336 | +9.81% | |
| Comprehensive Financial Management Llc | 0.11% | 941,895 | $3,456,755 | $3,795,837 | +$339,082 | +9.81% | |
| Stifel Financial Corp | 0.00% | 881,457 | $3,234,974 | $3,552,272 | +$317,298 | +9.81% | |
| Citigroup Inc | 0.00% | 864,403 | $3,172,359 | $3,483,544 | +$311,185 | +9.81% | |
| Creative Planning | 0.00% | 749,588 | $3,095,799 | $3,020,840 | -$74,959 | -2.42% | |
| Invesco Ltd. | 0.00% | 795,698 | $2,920,211 | $3,206,663 | +$286,452 | +9.81% | |
| Group One Trading Llc | 0.08% | 783,035 | $2,873,738 | $3,155,631 | +$281,893 | +9.81% | |
| Man Group Plc | 0.01% | 765,786 | $2,810,435 | $3,086,118 | +$275,683 | +9.81% | |
| National Bank Of Canada | 0.00% | 739,631 | $2,714,446 | $2,980,713 | +$266,267 | +9.81% | |
| Price T Rowe Associates Inc | 0.00% | 720,097 | $2,643,000 | $2,901,991 | +$258,991 | +9.80% | |
| Bnp Paribas Asset Management Holding S.A. | 0.00% | 712,776 | $2,615,888 | $2,872,487 | +$256,599 | +9.81% | |
| Vestmark Advisory Solutions, Inc. | 0.02% | 708,858 | $2,601,509 | $2,856,698 | +$255,189 | +9.81% | |
| Lazard Asset Management Llc | 0.00% | 692,378 | $2,541,027 | $2,790,283 | +$249,256 | +9.81% | |
| Dnb Asset Management As | 0.01% | 685,901 | $2,517,257 | $2,764,181 | +$246,924 | +9.81% | |
| Rhumbline Advisers | 0.00% | 651,214 | $2,389,943 | $2,624,392 | +$234,449 | +9.81% | |
| Rafferty Asset Management, Llc | 0.01% | 613,612 | $2,251,956 | $2,472,856 | +$220,900 | +9.81% | |
| Pivotal Bioventure Partners Investment Advisor Llc | 0.71% | 595,518 | $2,185,551 | $2,399,938 | +$214,387 | +9.81% |
Frequently asked questions about RXRX
Who are the largest institutional holders of RXRX?
The largest institutional holders of RXRX reported in the latest SEC Form 13F filings include Blackrock, Inc., ARK Invest, State Street Corp, Vanguard Portfolio Management Llc, and Baillie Gifford & Co. InsiderSet ranks institutional holders by their latest reported RXRX position.
What is RXRX institutional ownership?
This page tracks RXRX positions reported by institutional investment managers through SEC Form 13F. RECURSION PHARMACEUTICALS-A (RXRX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own RXRX?
InsiderSet currently tracks 325 institutional managers reporting RXRX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of RXRX shareholders.
How much RXRX stock do institutions own?
Institutional investment managers disclosed approximately $1.33B in RXRX holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was RXRX institutional ownership last updated?
The latest RXRX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional RXRX holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its RXRX position after the reporting date.
Are institutions buying or selling RXRX?
Institutional buying and selling can be analyzed by comparing RXRX positions across consecutive 13F reporting periods. InsiderSet's RXRX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View RXRX ownership changes.
How has RXRX institutional ownership changed over time?
InsiderSet tracks RXRX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.